Det r 4500 fler personer n lsret innan, enligt CSN
Heres how different groups responded to treatment: Race and Ethnicity : Clinical benefits were consistent across all racial and ethnic groups Type 2 Diabetes : Patients without diabetes achieved higher total body weight loss (16.9%) versus those with diabetes (9.9%) at 12 months Body Mass Index (BMI) : After two years of treatment, 52.4% of participants moved down at least one BMI category Results show that 12% of adults receiving semaglutide reached a healthy BMI of 25 kg/m or less, compared to only 1.2% in the placebo group
These medications work by mimicking glucagon-like peptide-1, a hormone naturally produced by the body that plays a key role in appetite regulation, digestion, and metabolic function
Plaintiffs allege that many patients were not adequately warned that delayed gastric emptying could become severe, prolonged, or medically disruptive
Highlights of Prescribing Information: Wegovy (semaglutide) injection for subcutaneous use Wegovy (semaglutide) tablets, for oral use